1
Please read our latest review by @jan_choutka et al. on “Unexplained post-acute infection syndromes”.
What a privilege to work with Jan Choutka, who is an #MECFS patient, expert and advocate. Grateful to @mhornig on her expertise/insights 🙏🏼 (1/)
nature.com/articles/s4159…
2
3
4
Reflection: persistent viral RNA has been seen post-COVID and after other viral infections. Targeting and getting rid of such RNA may hold key to the treatment of #longCOVID and #MECFS patients who suffer from this pathogenesis. (End)
5
@cstroeckw Many thanks to you and other patient advocates, this pandemic has propelled me to investigate the pathobiology of #longCOVID, #MECFS and #longLyme 🙏🏼 If enough people do the same, we can change how society and medicine view post-acute infection syndromes.
6
Such an honor to discuss with Prof. Ron Davis of @StanfordMed about #MECFS - metabolism, chemistry, viruses and immunology!
Start of a great collaboration.
7
Thank you @ASlavitt for speaking up about #longCOVID 🙏🏼 We need a lot more public attention, research, therapy and drugs to combat this debilitating disease. We also need similar attention/resources/research/treatment for #MECFS that results after infection with other pathogens. twitter.com/ASlavitt/statu…
8
So grateful to receive the 2022 Johadamis ME/CFS Research Grant! In collaboration with @polybioRF @BjornBragee we will test blood & CSF samples from #MECFS patients for immune phenotypes and antibodies to various pathogens. This will inform us about potential drivers of disease. twitter.com/Tempi_Stiftung…